What's New
Stay up to date with the latest features, improvements, and fixes in SmartCemic.
4
Releases
114+
Biomarkers
46
Export Formats
Healthcare interoperability exports and enhanced PWA support.
- Real-time biomarker trend analysis with ML predictions
- FHIR R4, HL7 v2.5.1, and CDA R2 healthcare interoperability exports
- LOINC code support for standardised lab result integration
- Progressive Web App (PWA) support for offline measurements
- Dark/Light theme toggle with system preference detection
- Accessibility widget with color blindness filters
- Device connection stability with enhanced BLE GATT handling
- Improved calibration handling
- Faster dashboard loading
- Mobile responsive design across all pages
- API documentation with interactive "Try It" endpoints
- Mobile hamburger menu scrolling on iOS devices
- Device card alignment and centering issues
- Session persistence across browser refreshes
- Timezone handling for measurement timestamps
Introduced quantum-enhanced spectral analysis engine and third-party health platform integrations.
- Quantum-enhanced spectral analysis (QESA) measurement engine
- Multi-biomarker simultaneous tracking (glucose, lactate, ketones, hydration)
- Wellness score algorithm with personalized health insights
- Integration with Google Fit, Apple Health, and Fitbit
- Email and push notification alerts for out-of-range values
- HIPAA-compliant data encryption at rest and in transit
- JWT token refresh with automatic session management
- Two-factor authentication support
Initial public release of SmartCemic platform with core tracking features.
- Initial release of SmartCemic platform
- BLE device pairing and management
- Real-time glucose tracking dashboard
- Historical data visualization with charts
- PDF report generation and export
- User account management and profiles
Beta launch with core spectral analysis technology for limited testing program.
- Beta launch of non-invasive tracking technology
- Core spectral analysis algorithms
- Prototype device firmware integration
- Limited user beta testing program
